Thus, STING inhibitor might represent a potential therapeutic adjuvant in combination with routine steroid treatment to enhance steroid sensitivity and to control lung inflammation and remodeling, thereby preventing COPD progression. This evidence concerns the gene STING1 and chronic obstructive pulmonary disease.